29,607
Participants
Start Date
February 28, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Mailer
Henry Ford intentifies patients meeting birth cohort screening criteria and then sends mailers to those individuals. Mailers contained HCV guidelines, the importance of screening, laboratory slips and locations for patients to act directly on their own behalf. If patients do not respond to the initial mailer, Henry Ford sends additional mailers.
In-person recruitment
UAB used study coordinators to actively screen and recruit patients who met the inclusion criteria for birth-cohort screening. Study coordinators were located at two internal medicine clinics, where they approached eligible participants in person. A control group was pulled from an additional two internal medicine clinics, which screened using a risk-based strategy. A cross-over approach was used, so that the intervention and control clinics switched at the midpoint of data collection, allowing all four clinics to participate in both arms of the study.
EHR Alert
EHR include a Best Practice Alert (BPA) prompting the Medical Assistant and/or clinican to order a Hepatitis C lab test for patients in the birth cohort.
Mt. Sinai Medical Center, New York
University of Alabama, Birmingham, Birmingham
Henry Ford Health System, Detroit
Lead Sponsor
NORC at the University of Chicago
OTHER
University of Alabama at Birmingham
OTHER
Henry Ford Health System
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
Centers for Disease Control and Prevention
FED
National Opinion Research Center
OTHER